PERLARA
Perlara, PBC is the first Public Benefit Corporation accelerating precision drug discovery for 5,000+ rare genetic diseases. PLab uses a platform of CRISPR-engineered animal models (yeast, nematodes, fruit flies and zebrafish) in whole-organism phenotypic screens to generate disease-reversing orphan drug candidates much faster and cheaper than traditional in vitro and cell-based approaches. Their lead discovery programs are Niemann-Pick Type C, a lysosomal storage disorder first described nearly... a century ago, and NGLY1 Deficiency, a congenital disorder of glycosylation first diagnosed last year. Their initial pipeline includes, among others, additional lysosomal storage disorders, e.gs, Batten and Mucolipidosis IV, mitochondrial diseases, e.g., Leigh, and peroxisomal biogenesis disorders, e.g., Zellweger.
PERLARA
Industry:
Biotechnology Genetics Medical Pharmaceutical Therapeutics
Founded:
2014-02-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.perlara.com
Total Employee:
1+
Status:
Active
Contact:
+1 415 952 0559
Total Funding:
11.76 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Content Delivery Network Google Maps GStatic Google Static Content Sectigo SSL Sectigo Domain SSL Pound Sterling Wix
Current Advisors List
Board_member
Board_member
2014-11-01
Current Employees Featured
Richard Sachs VP Creative Services @ Perlara
VP Creative Services
Ethan Oren Perlstein CEO @ Perlara
CEO
2014-02-01
Nina DiPrimio Director of Research and Development @ Perlara
Director of Research and Development
2017-12-01
Founder
Investors List
Homebrew
Homebrew investment in Series A - Perlara
Slow Ventures
Slow Ventures investment in Seed Round - Perlara
Y Combinator
Y Combinator investment in Seed Round - Perlara
Techammer
Techammer investment in Seed Round - Perlara
Travere Therapeutics
Travere Therapeutics investment in Seed Round - Perlara
Newest Events participated
Participated in Y Combinator Winter 2016 Demo Day
on 2016-03-22 as exhibitor
Official Site Inspections
http://www.perlara.com Semrush global rank: 2.31 M Semrush visits lastest month: 8.08 K
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.171
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Perlara"
about - Perlara
Perlara 1.0 proved that you could create joint ventures with individual families battling the long tail of disease. Perlara 2.0 will prove that you can build a fully decentralized biotech that partners with entrepreneurial families anywhere in …See details»
Perlara | Guided Curesâ„¢
Finding treatments and cures for your disease is complex and often unmanageable. Perlara Cure Guides ™ are top researchers and clinicians who are passionate about finding cures. They …See details»
Perlara PBC: accelerate the discovery of cures across diseases
Perlara was originally founded as Perlstein Lab, PBC in February 2014. Perlara is the first biotech Public Benefit Corporation (bioPBC) based in the Bay Area that is on a mission to accelerate …See details»
Perlara FAQs. Learn more about Perlara PBC and PerlQuests.
Perlara PBC was originally founded as Perlstein Lab, PBC in February 2014. Perlara, PBC is a biotech platform company and Public Benefit Corporation (bioPBC). based in the San …See details»
Perlara - Crunchbase Company Profile & Funding
Perlara, PBC is the first Public Benefit Corporation accelerating precision drug discovery for 5,000+ rare genetic diseases. PLab uses a platform of CRISPR …See details»
Perlara Company Profile 2024: Valuation, Funding & Investors
Perlara General Information Description. Developer of a drug discovery platform designed to cure rare diseases and learn how genes work across diseases. The company's platform creates …See details»
Perlara: Perlara: building the YC for rare disease …
Perlara 1.5 (March 2019 - April 2020) was the transition to a one-person virtual clinical development company and when the epalrestat and aripiprazole repurposing trials were launched at Mayo Clinic for the treatment of PMM2 …See details»
Perlara - VentureRadar
Perlara embarks on journeys of scientific discovery and drug development called PerlQuests™ with families, patient organizations and BioPharma and clinical partners. The PerlArk™ …See details»
Perlara Company Profile - Office Locations, Competitors ... - Craft
Perlara, PBC is a biotech company on a mission to discover personalized cures for diseases rare and common. The Company develops a Drug Discovery Platform that is based on creating …See details»
Perlara is a Public Benefit Corporation accountable for …
Straightforward and timely communication is foundational to Perlara. We honor our commitments. Strength in diversity. Perlara’s team reflects our world. Every age, sex, expertise and continent is represented. We share an enthusiasm for …See details»
Perlara CEO Ethan Perlstein on reviving a biotech and building a ‘Y ...
Sep 27, 2022 Perlstein speaks a mile a minute, the same kind of energy he’s applied to his work at Perlara, the biotechnology company he founded in 2014 focusing on rare diseases. …See details»
Perlara PBC - Drug pipelines, Patents, Clinical trials - Synapse
Nov 1, 2024 Explore Perlara PBC with its drug pipeline, therapeutic area, technology platform, 7 news, and 4 literature, Disease Domain:Endocrinology and Metabolic Disease, Hemic and …See details»
FAQ | Perlara
Perlara’s finance department invoices clients for all project fees on the schedule outlined in the relevant Statement of Work, as well as any pass-along costs such as subcontracts and …See details»
Perlara announces n=1 drug discovery pact with Mission: Cure
Perlara, a rare diseases drug discovery platform company partnering with highly motivated families, foundations and drug developers, today announced a PerlQuest partnership to cure …See details»
Perlara signs rare disease pact with Novartis
Oct 24, 2016 In a critical validation for a biotech firm espousing an unusual business model, Perlara has struck a deal to develop lysosomal storage disorder treatments with Novartis. The …See details»
services - Perlara
Experience Perlara's groundbreaking services that redefine cure and treatment solutions. Our Drug Repurposing Screening identifies potential treatments from existing drugs, while …See details»
Perlara PBC is working with families to develop cures for rare …
Welcome to the archival website of Perlara 1. Take a look around at the foundations of Perlara’s exciting new Guided Cures™ Journey . Perlara scientists are working with highly motivated …See details»
Ethan Perlstein is Chief Executive Officer at Perlara.
Ethan Perlstein, PhD | CEO. Over the course of the last decade, first as a graduate student at Harvard University in the Department of Molecular and Cell Biology with PhD advisor …See details»
Cure Guides - Perlara
You will lead world-class, globally distributed research teams and families through the planning and development of innovative cure and treatment paths that can leverage your passion and …See details»
Scalable drug discovery platform - Perlara
Dec 20, 2018 Perlara uses a platform of genetically engineered animals (yeast, nematodes, fruit flies and zebrafish) in phenotypic screens to identify orphan drug candidates that reverse …See details»